US20040211429A1 - Contraceptive transcervical fallopian tube occlusion devices and their delivery - Google Patents

Contraceptive transcervical fallopian tube occlusion devices and their delivery Download PDF

Info

Publication number
US20040211429A1
US20040211429A1 US10846047 US84604704A US2004211429A1 US 20040211429 A1 US20040211429 A1 US 20040211429A1 US 10846047 US10846047 US 10846047 US 84604704 A US84604704 A US 84604704A US 2004211429 A1 US2004211429 A1 US 2004211429A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
body
fallopian tube
method
delivery system
portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10846047
Inventor
Julian Nikolchev
Dai Ton
Amy Thurmond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Essure Inc
Original Assignee
Bayer Essure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/20Vas deferens occluders; Fallopian occluders
    • A61F6/22Vas deferens occluders; Fallopian occluders implantable in tubes
    • A61F6/225Vas deferens occluders; Fallopian occluders implantable in tubes transcervical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/1215Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/18Inserters or removers ; Apparatus for loading an intra-uterine device into an insertion tube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/20Vas deferens occluders; Fallopian occluders
    • A61F6/22Vas deferens occluders; Fallopian occluders implantable in tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices

Abstract

The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or a copper alloy. The device is anchored within the fallopian tube by imposing a secondary shape on a resilient structure, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. The resilient structure is then restrained by the walls of the fallopian tube, imposing anchoring forces as it tries to resume the secondary shape.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0001]
  • The present invention relates generally to contraception, and more particularly to intrafallopian contraceptive devices and nonsurgical methods for their delivery. [0002]
  • Worldwide demand exists for safe, effective methods of both contraception and permanent sterilization. Although a variety of contraception and sterilization methods are available, all of the existing methods have limitations and disadvantages. Thus, the need for additional safe, low cost, reliable methods of contraception and permanent sterilization, both in developed and less developed countries, is widely recognized. [0003]
  • Many presently available contraception methods require significant user involvement, and user non-compliance results in quite high rates of failure. While the theoretical effectiveness of existing contraceptives, including barrier methods and hormonal therapies, is well established, overcoming user noncompliance to improve overall efficacy has proven difficult. [0004]
  • One form of contraception which is less susceptible to user noncompliance is the intrauterine device (IUD). IUDs have been found to have higher rates of reliability, and are effective for a longer period of time, than most other commercially available contraceptives. Unfortunately, IUDs are also associated with serious infectious complications. For this reason, the use of IUDs within the United States has decreased dramatically. Additionally, IUDs are subject to unplanned expulsion, and must be removed due to excessive pain or bleeding in a percentage of cases, further reducing the acceptance of the IUD as a contraceptive method. Interestingly, the efficacy of copper IUDs appears to be higher than that of non-metallic IUDs. The reason for this has not been fully explained. [0005]
  • Commercially available options for permanent sterilization include fallopian tube ligation and vasectomy. These methods are surgical, are difficult to reverse, and are not available to many people in the world. It is common knowledge that fertilization occurs in the fallopian tubes where the sperm and ovum meet. Tubal ligation avoids this by complete occlusion of the fallopian tubes. [0006]
  • It has previously been proposed to reversibly occlude the fallopian tubes, for example, by in vitro formation of an elastomeric plug, or otherwise anchoring a device on either side of the narrowest region of fallopian tube, called the “isthmus.” Such fallopian tube occlusion methods appear promising; however, an unacceptably high percentage of the non-surgical devices proposed to date have become dislodged during previous studies. Even where non-surgical intrafallopian devices have remained in place, they have been found to be only moderately effective at preventing conception. [0007]
  • For these reasons, it would be desirable to provide effective, reliable intrafallopian devices for contraception and sterilization. It would be particularly desirable to provide highly effective intrafallopian devices which did not require surgery for placement. It would be especially desirable if such devices and methods allowed easy placement of the device, but were less susceptible to being dislodged than previously proposed non-surgical intrafallopian devices. [0008]
  • 2. Description of the Related Art [0009]
  • The experimental use of a stainless steel intrafallopian device is described in [0010] Transcatheter Tubal Sterilization in Rabbits, Penny L. Ross, RT 29 “Investigative Radiology”, pp. 570-573 (1994). The experimental use of an electrolytically pure copper wire as a surgical contraceptive intrafallopian device in rats was described in “Antifertility Effect of an Intrafallopian Tubal Copper Device”, D. N. Gupta, 14 Indian Journal of Experimental Biology, pp. 316-319 (May 1976).
  • U.K. Patent Application Pub. No. 2,211,095 describes a uterine screw plug for blocking the fallopian tube. European Patent Application Pub. No. 0,010,812 describes a device for placement in the oviducts having enlargements at either end for anchoring the device. The same device appears to be described in Netherlands Patent No. 7,810,696. [0011]
  • The use of tubal occlusion devices is described in “Hysteroscopic Oviduct Blocking With Formed-in-Place Silicone Rubber Plugs”, Robert A. Erb, Ph.D., et al., [0012] The Journal of Reproductive Medicine, pp. 65-68 (August 1979). A formed-in-place elastomeric tubal occlusion device is described in U.S. Pat. No. 3,805,767, issued to Erb. U.S. Pat. No. 5,065,751, issued to Wolf, describes a method and apparatus for reversibly occluding a biological tube. U.S. Pat. No. 4,612,924, issued to Cimber, describes an intrauterine contraceptive device which seals the mouths of the fallopian tubes.
  • German Patent No. 28 03 685, issued to Brundin, describes a device for plugging a body duct with a device which swells when in contact with a body fluid. [0013]
  • Alternative contraceptive devices are disclosed in copending U.S. patent application Ser. No.______ (attorney docket no. 16355-25), the full disclosure of which is herein incorporated by reference. [0014]
  • SUMMARY OF THE INVENTION
  • The present invention provides intrafallopian devices and methods for their placement to prevent conception. The intrafallopian devices of the present invention are transcervically delivered, resiliently anchored structures which are formed at least in part from copper to provide long term contraception, or alternatively permanent sterilization, without the need for surgical procedures or the increased bleeding, pain, and risks of infection associated with intrauterine devices (IUDs). [0015]
  • The use of copper in the intrafallopian device of the present invention improves its efficacy as a contraceptive method. Devices formed from plastically deformable materials, however, are less readily restrained in the fallopian tube. Apparently, the large variation in the actual shape and dimensions of fallopian tubes does not provide reliable anchoring for a pre-formed deformable intrafallopian device. The intrafallopian device of the present invention therefore comprises a resilient structure, usually a metallic coil, which includes a copper alloy, a copper plating, or copper fibers, ideally comprising an alloy including at least 75% copper. The coil material typically includes beryllium, zinc, stainless steel, platinum, a shape memory alloy such as Nitinol™, or the like. Preferably, the coil is composed of an alloy of beryllium and copper. Although the present device will generally result in occlusion, it need not completely occlude the fallopian tube to prevent the meeting of the sperm and ovum. Instead, the presence of the copper on the resilient structure is sufficient to provide effective contraception. [0016]
  • Conveniently, the present invention further comprises non-surgical placement of such intrafallopian devices by transcervical introduction. The resilient structure is restrainable in a straight configuration, e.g., by inserting the device within a catheter, greatly facilitating and reducing the risks of introduction. Thus, the cost and dangers associated with existing surgical contraceptive and sterilization procedures are avoided. [0017]
  • In a first aspect, a contraceptive intrafallopian device according to the present invention comprises a resilient structure having a proximal end and a distal end. The resilient structure comprises copper, and is biased to form at least one bend near the proximal end of the primary coil. Similarly, the resilient structure is also biased to form at least one bend near its distal end. These proximal and distal bends define an isthmus-traversing region therebetween. Preferably, the isthmus-traversing region also includes at least one bend, thereby helping to anchor the coil within the fallopian tube. [0018]
  • Generally, the resilient structure of the present intrafallopian device will be formed as a primary coil. To help restrain the coil within the fallopian tube, fibers are attached to some embodiments of the coil, the fibers optionally comprising a polyester material such as Rayons™, Dacron™, or the like. Alternatively, copper fibers may be used to increase the exposed copper surface area, the copper fibers generally having a diameter on the order of 0.001 inches. [0019]
  • The bends of the present intrafallopian device are generally formed as a secondary shape imposed on a primary coil. The primary coil is most easily formed as a straight cylindrical coil. The secondary shape will be imposed on the primary coil by bending, optionally heat treating the primary coil while bent. The individual bends may take a wide variety of forms, including sinusoidal curves, the individual loops of a continuous secondary coil, or the like. However, the secondary shape generally defines an overall width which is larger than the fallopian tube, so that the tubal wall restrains the resilient structure when it is released. [0020]
  • Preferably, each of the bends of the present intrafallopian device forms a loop in the primary coil when in a relaxed state. Ideally, the loops are separated by straight sections of coil. The alternating of loops with straight sections of coil forms a large diameter “flower coil,” which provides a large relaxed overall width, and also features bends of tight radius, both of which promote retention. Conveniently, the primary coil generally has a diameter less than that of the fallopian tube, and can be restrained in a straight configuration for placement within the fallopian tube, typically by inserting the primary coil within a delivery catheter. [0021]
  • In another aspect, a contraceptive intrafallopian device according to the present invention comprises a resilient primary coil having a primary coil diameter. The primary coil comprises copper, and forms a secondary shape when in a relaxed state. The secondary shape defines a plurality of bends and an overall width which is larger than the primary coil diameter. Thus the primary coil can be easily anchored in a fallopian tube which is smaller in diameter than the secondary shape. Preferably, the present device reacts with a force sufficient to prevent axial movement of the device within the fallopian tube when restrained in a lumen having a diameter in the range between 0.5 mm and 3 mm. The actual anchoring force will depend on the shape of the coil and the modulus of elasticity of the material used. [0022]
  • In yet another aspect, a intrafallopian contraceptive delivery system according to the present invention comprises an elongate body in which the resilient primary coil described above is slidably disposed. A shaft is also slidably disposed within the elongate body and is located proximally of the primary coil. The distal end of the shaft includes a coil interface surface, while the elongate body restrains the primary coil in a straight configuration. [0023]
  • Preferably, a bend in the isthmus-traversing region of the present intrafallopian device, together with the proximal and distal anchor bends, restrains the resilient structure within the isthmus of the fallopian tube. The distal anchor is inserted into the ampulla, distal of the isthmus, while the proximal anchor is located in the ostium, proximal of the isthmus. Unintended movement of the device is further avoided by locating the isthmus-traversing region within the isthmus to resiliently impose anchoring forces against the tubal wall. [0024]
  • In a still further aspect, an intrafallopian contraceptive method according to the principles of the present invention comprises restraining a resilient structure in a straight configuration and transcervically inserting the resilient structure into a fallopian tube. The resilient structure is affixed within the isthmus by releasing a bent isthmus-traversing region. The bend of the isthmus-traversing region exerts a force against the wall of the fallopian tube, anchoring the device within the isthmus. Preferably, a distal anchor on the resilient structure is released distally of the isthmus, and a proximal anchor is released proximally of the isthmus, the distal and proximal anchors generally formed from bends in the resilient structure. Optionally, an electric current is applied through the resilient structure to the fallopian tube, thereby effecting permanent sterilization.[0025]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates a first embodiment of a contraceptive intrafallopian device according to the present invention having a single distal anchor loop, a single proximal anchor loop, and an isthmus-traversing region having a single loop for anchoring the device within the fallopian tube. [0026]
  • FIG. 2 illustrates an alternative embodiment of a contraceptive intrafallopian device according to the present invention having a plurality of loops which may act as proximal, distal, or lumen anchors. [0027]
  • FIG. 3 illustrates the distal portion of a delivery catheter for placement of a contraceptive intrafallopian device according to the present invention. [0028]
  • FIG. 4 illustrates the contraceptive intrafallopian device of FIG. 1 partially released from the delivery catheter of FIG. 3. [0029]
  • FIGS. 5 and 6 illustrate a contraceptive method using an intrafallopian device according to the principles of the present invention.[0030]
  • DETAILED DESCRIPTION OF THE SPECIFIC EMBODIMENT
  • The present invention encompasses a contraceptive intrafallopian device which can alternatively be used as both a permanent and a reversible means of contraception. The present contraceptive methods and devices minimize the danger of non-use which has limited the efficacy of prior art contraceptive techniques. Moreover, the location of the present devices within the fallopian tubes provides a reduced risk of the infectious complications, increased bleeding, and pelvic pain associated with intrauterine devices (IUDs). Furthermore, the location and the novel shape of the present intrafallopian device provides significant advantages over IUDs, which have been found to be susceptible to unplanned expulsion and removal due to excessive pain and bleeding. The present invention takes advantage of the increase in effectiveness associated with copper IUDs, providing a resilient structure including copper which may be transcervically positioned without the need for surgery. [0031]
  • Although the present contraceptive method may be included within a group of contraceptive techniques generally referred to as fallopian tube occlusion methods, the present invention does not necessarily rely solely on blocking the fallopian tube to prevent fertilization. Instead, contraception is apparently provided by disrupting of ovum transport, the process of fertilization, and/or cleavage of the ovum. While the effect that copper has on these processes is not fully understood, it does appear that copper intrafallopian devices offer potentially significant increases in effectiveness over intrafallopian devices formed of other materials. Optionally, the present invention further encompasses devices which promote tissue growth within the tube to induce tubal occlusion, further inhibiting conception. [0032]
  • The present invention is anchored within the isthmus of the fallopian tube, overcoming the unintended expulsion of the device and the resulting failure of the contraceptive method. Such intrafallopian device expulsion has been the single greatest factor limiting the efficacy of easily positioned intrafallopian contraceptive techniques. [0033]
  • The present intrafallopian devices are generally elongate resilient structures pre-formed into secondary shapes. These secondary shapes will bias the resilient structure so as to provide strong forces against the lumen wall of the fallopian tube. Clearly, the secondary shape must have a larger outer diameter than the inner diameter of the fallopian tube. [0034]
  • Conveniently, the present resilient structures are insertable into a catheter, the catheter wall restraining the resilient structure in a straight configuration. As the resilient structure has an outer diameter when in the straight configuration which is less than the inner diameter of the fallopian tube, the catheter containing the present intrafallopian device is easily transcervically introduced. Moreover, the device is readily removed by snaring the resilient structure near the proximal end and pulling proximally on the resilient structure, thereby straightening the resilient structure and allowing it to be withdrawn without injuring the fallopian tube. Alternatively, an electrical current is applied to the device after it is at least partially releasing the fallopian tube, providing permanent sterilization. [0035]
  • Referring now to FIG. 1, a first embodiment of the present contraceptive intrafallopian device [0036] 10 is formed from a resilient primary coil 12. Primary coil 12 is most easily originally formed as a straight cylindrical coil or spring, preferably having an outer diameter in the range from 0.2 mm to 5 mm, and having a length in the range from 20 mm to 150 mm. Ideally, primary coil 12 has an outer diameter in the range from 0.4 mm to 2 mm and a length in the range from 30 mm to 70 mm. The straight primary coil may then be bent into a variety of secondary shapes.
  • The primary coil [0037] 12 of intrafallopian device 10 includes a proximal end 14 and a distal end 16. Between these ends, three loops 20 are formed, each having an inner diameter 22. Located between loops 20 are straight sections 24, which increase the overall cross-section of the intrafallopian device to an overall width 26. Preferably, inner diameter 22 is in the range from 2 mm to 10 mm, while overall width 26 is at least 6 mm, ideally being in the range from 8 mm to 40 mm. Distal and proximal ends 14, 16 each include an atraumatic endcap 18 to prevent injury to the fallopian tube.
  • Preferably, primary coil [0038] 12 is formed from a beryllium copper alloy wire. Beryllium copper provides the resilience necessary to avoid expulsion of the device, and also provides the increased effectiveness of a copper contraceptive intrafallopian device. Alternatively, primary coil 12 is formed from a resilient metal, such as stainless steel, platinum, a shape memory alloy, or the like. If such materials are used, primary coil 12 is preferably plated with copper or a copper alloy or otherwise has copper attached.
  • To further reduce the possibility of expulsion of intrafallopian device [0039] 10, fibers are optionally carried on primary coil 12. The fibers may be short individual fibers, or may alternatively be wound into primary coil 12. Preferably, the fibers comprise copper, thereby increasing the total copper surface area. Such copper fibers are preferably bonded to primary coil 12 with solder, brazing, a polymeric adhesive, or the like. Alternatively, polyester fibers such as Dacron™, Rayon™, or the like, are bonded to the surface of primary coil 12 using a polymeric adhesive. The polyester fibers promote increased tissue growth around the coil, thus further reducing the possibility of expulsion of the device from the fallopian tube.
  • A secondary shape has been superimposed on the primary coil to form intrafallopian device [0040] 10, the secondary shape comprising loops 20 separated by straight sections 24. This secondary shape is herein referred to as a “flower coil.” The flower coil shape is particularly advantageous in that outer diameter 26 is substantially larger than the primary coil diameter, while the individual loops 20 have relatively small inner diameters 22 which will maintain the largest possible anchoring force against the fallopian tube. Minimizing inner diameter 22 also ensures that anchoring force is applied within the fallopian tube, despite the curvature of the fallopian tube.
  • Referring now to FIG. 2, an alternative embodiment of the present contraceptive intrafallopian device [0041] 30 includes additional loops to ensure anchoring of the device within the fallopian tube. Alternative embodiment 30 is formed from an elongate primary coil 32 having a proximal end 34 and a distal end (not shown). Elongate primary coil 32 has an outer diameter 36 which is smaller than the isthmus of the fallopian tube, allowing the straightened intrafallopian device to be inserted easily. Elongate primary coil 32 has been bent to form a secondary shape including a larger number of loops 38 than the embodiment of FIG. 1. Loops 38 have an outer diameter 40 which is larger than the inner diameter of the fallopian tube, preventing loops 38 from assuming their relaxed shape. Loops 38 are again separated by straight sections 42 of elongate primary coil 32, increasing the overall intrafallopian device diameter 44.
  • In both embodiments of the present intrafallopian device [0042] 10, 30, at least one loop adjacent to the proximal end is disposed proximally of the narrowest portion of the fallopian tube, referred to as the isthmus. Similarly, at least one loop of the intrafallopian device is disposed distally of the isthmus. These proximal and distal loops act as anchors, helping to prevent proximal or distal movement of the intrafallopian device. In the embodiment of FIG. 2, at least one loop is also disposed adjacent to the isthmus of the fallopian tube, further helping to prevent unintentional expulsion.
  • Alternative intrafallopian device [0043] 30 may be positioned with multiple loops acting as proximal or distal anchors, or may alternatively have all but the proximal and distal anchor loops disposed along the fallopian tube to act as anchors within the lumen of that body. Advantageously, the embodiment of FIG. 2 is therefore less sensitive to variations in total fallopian tube length.
  • Referring now to FIG. 3, a delivery catheter for the present intrafallopian device comprises an elongate body [0044] 52 and a shaft 54. Elongate body 52 includes a lumen 56 in which shaft 54 is disposed, shaft 54 being slidable in the axial direction. Shaft 54 includes a core 58 having a tapered distal end 60, allowing the device to navigate through tortuous bends while retaining the column strength required to advance the device. Core 58 extends proximally through elongate body 52, and is capable of transferring compressive forces through the elongate body. Core 58 is typically formed from stainless steel, a stainless alloy, or the like. Disposed over distal end 60 of core 58 is pusher cap 62. Pusher cap 62 provides a low friction, deformable end piece having a distal coil interface surface 64. Pusher cap 62 is preferably formed of a low friction polymer such as PTFE, or the like.
  • Intrafallopian delivery catheter [0045] 50 receives the present intrafallopian device within the distal end of lumen 56 of elongate body 52. Lumen 56 has an inner diameter which is slightly larger than outer diameter 36 of the primary coil. The present intrafallopian device is therefore straightened to a straight configuration as it is loaded proximally into the distal end of lumen 56. Elongate body 52 is sufficiently strong to restrain the primary coil in the straight configuration, but must remain sufficiently flexible to allow maneuvering within the body lumen. Elongate body 52 is preferably formed from an inelastic, flexible material such as polyurethane, PET, or the like.
  • Referring now to FIG. 4, intrafallopian device [0046] 10 is released from delivery catheter 50 within the fallopian tube by holding shaft 54 while proximally withdrawing elongate body 52. Distal coil interface surface 64 engages the proximal end 14 of primary coil 12. Initially, primary coil 12 is restrained in a straight configuration by elongate body 52. As elongate body 52 is withdrawn, primary coil 12 is released. When primary coil 12 is unrestrained it forms loop 20; when released within the fallopian tube it will generally be restrained by the tubal wall in a configuration between straight and the relaxed secondary shape. Preferably, the first loop released will form a distal anchor bend 66. Subsequent loops will bias primary coil 12 against the fallopian tube, and form a proximal anchor bend, in that order.
  • Use of the present contraceptive intrafallopian device will be described with reference to FIGS. 5 and 6. A uterine introducer canula [0047] 70 is inserted transcervically through a uterus 72 to the region of an ostium 74. Elongate body 52 is then extended distally from canula 70 into a fallopian tube 77, preferably guided under fluoroscopy. Alternatively, a hysteroscope may be used in place of canula 70. Elongate body 52 is maneuvered using a guide wire 78 past an isthmus 80.
  • After elongate body [0048] 52 extends past isthmus 80, guide wire 78 is removed. An intrafallopian device according to the present invention is inserted in the proximal end of elongate body 52, the intrafallopian device being restrained in a straight configuration by the elongate body. The device is advanced distally using shaft 54, the shaft and elongate body forming delivery catheter 50 (FIG. 3). Delivery catheter 50 is axially positioned so that at least one loop of the intrafallopian device is within a target region 84 adjacent to isthmus 80. Preferably, at least one loop is distal of target region 84, and at least one loop is proximal of target region 84 to form the distal and proximal anchor bends of the implanted intrafallopian device.
  • Once delivery catheter [0049] 50 is properly positioned, elongate body 52 may be axially withdrawn. Shaft 54 axially restrains the intrafallopian device at the target location during withdrawal of elongate body 52, as described regarding FIG. 4. As the distal end of the primary coil is released, the distal loop forms a distal anchor bend 90. Similarly, the proximal loop forms a proximal anchor bend 92. Intermediate loops are restrained within the narrow target region 84, exerting substantial anchoring forces against the walls of the fallopian tube. As seen in FIG. 6, the loops need not assume their relaxed form to provide effective distal or proximal anchors.
  • The present invention further encompasses permanent sterilization by passing a current through the shaft to the intrafallopian device after elongate body [0050] 52 has been partially withdrawn, but before the intrafallopian device is fully released. Fallopian tube tissue in contact with the intrafallopian device is dessechated, and thus attached to the present intrafallopian device. This action also causes permanent tubal damage, leading to the formation of scar tissue which encapsulates the intrafallopian device and causes permanent occlusion of the tubal lumen. Clearly, the resilient member/shaft interface must be conductive to allow the present non-surgical method of permanent sterilization.
  • In conclusion, the present invention provides a contraceptive intrafallopian device which may be positioned without surgery. While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. For example, a wide variety of secondary shapes, including open loops, continuous bends, sinusoidal curves, or the like, may be imposed on the primary coil. Therefore, the above description should not be taken as limiting the scope of the invention, which is defined instead solely by the appended claims. [0051]

Claims (72)

  1. 1-31. (canceled)
  2. 32. A method for sterilizing a female patient using an elongated instrument assembly having a distal end, said method comprising:
    inserting the distal end of the elongated instrument assembly transcervically into the female patient, the distal end of the elongated instrument having a detachable body which includes a non-biodegradable material;
    applying energy from the elongated instrument to a surrounding tissue of a fallopian tube of said female patient;
    detaching the detachable body from the distal end of the elongated instrument assembly; and
    removing a remaining portion of the elongated instrument assembly from the female patient, wherein a scar formation in a region of the surrounding tissue permanently attaches to the detachable body.
  3. 33. The method of claim 32 wherein the energy comprises electrical energy and wherein the scar formation encapsulates the detachable body.
  4. 34. A method as in claim 32 wherein said detachable body is resilient and imposes an anchoring force against said surrounding tissue.
  5. 35. A method as in claim 32 wherein said elongated instrument assembly comprises a conductive interface which is coupled to a surface assembly which is coupled to said elongated instrument assembly.
  6. 36. A method as in claim 32 wherein said elongated instrument assembly comprises an elongate body and a shaft which is disposed within said elongate body.
  7. 37. A method as in claim 32 wherein said applying precedes said detaching of said detachable body.
  8. 38. A method as in claim 32 wherein said detachable body has a first configuration prior to said detaching and a second configuration after said detaching.
  9. 39. A method as in claim 38 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
  10. 40. A method as in claim 32 wherein said detachable body comprises a polymer material.
  11. 41. A method comprising:
    inserting a catheter having an electrically conductive surface assembly mounted on a distal end of the catheter through the vagina and the cervical canal of a patient and into the uterus of the patient;
    advancing a detachable assembly, which is coupled to the catheter, into a fallopian tube of the patient, said detachable assembly including a non-biodegradable material;
    applying electrical energy to the electrically conductive surface assembly;
    detaching the catheter from the detachable assembly, wherein a permanent scar formation in the fallopian tube encapsulates the detachable assembly.
  12. 42. A method as in claim 41 wherein said detachable assembly is resilient and imposes an anchoring force against the fallopian tube.
  13. 43. A method as in claim 41 wherein said catheter comprises a conductive interface which is coupled to said electrically conductive surface assembly.
  14. 44. A method as in claim 41 wherein said catheter comprises an elongate body and a shaft which is disposed within said elongate body.
  15. 45. A method as in claim 41 wherein said applying precedes said detaching of said detachable assembly.
  16. 46. A method as in claim 41 wherein said detachable assembly has a first configuration prior to said detaching and a second configuration after said detaching.
  17. 47. A method as in claim 46 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
  18. 48. A method as in claim 41 wherein said detachable assembly comprises a polymer material.
  19. 49. A method as in claim 44 wherein said catheter further comprises a lumen through which said shaft is slidable.
  20. 50. A method as in claim 41 wherein said applying said electrical energy is through a shaft within a lumen of said catheter.
  21. 51. An intrafallopian delivery system for transcervical introduction of a device, the delivery system comprising:
    a first portion having an elongate body and a shaft for delivering energy;
    a second portion detachably coupled to said elongate body, said second portion including a non-biodegradable material and being sized to fit within a fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube and wherein said energy causes a scar formation, in said fallopian tube, which attaches to said second portion.
  22. 52. A delivery system as in claim 51 wherein said energy comprises electrical energy and wherein said shaft delivers electrical current.
  23. 53. A delivery system as in claim 51 wherein said second portion is resilient and imposes an anchoring force against said fallopian tube.
  24. 54. A delivery system as in claim 51 wherein said shaft is disposed within a lumen of said elongate body.
  25. 55. A delivery system as in claim 51 wherein said energy is delivered before said second portion is detached from said elongate body.
  26. 56. A delivery system as in claim 51 wherein said second portion has a first configuration prior to being detached and a second configuration after being detached.
  27. 57. A delivery system as in claim 56 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
  28. 58. A delivery system as in claim 51 wherein said second portion comprises a polymer material.
  29. 59. A delivery system as in claim 51 further comprising an introducer through which said elongate body is inserted.
  30. 60. A delivery system as in claim 51 wherein said second portion has a surface which attaches to said scar formation.
  31. 61. An intrafallopian catheter system for transcervical introduction of an intrafallopian device, said catheter system comprising:
    an elongate body having a shaft for delivering electrical energy;
    a detachable body which is detachably coupled to said elongate body, said detachable body including a non-biodegradable material and being sized to fit within a fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube and wherein said electrical energy causes a scar formation, in said fallopian tube, which encapsulates said detachable body.
  32. 62. A catheter system as in claim 61 wherein said detachable body is resilient and imposes an anchoring force against said fallopian tube.
  33. 63. A catheter system as in claim 61 wherein said shaft is disposed within a lumen of said elongate body.
  34. 64. A catheter system as in claim 61 wherein said electrical energy is delivered before said detachable body is detached from said elongate body.
  35. 65. A catheter system as in claim 61 wherein said detachable body has a first configuration prior to being detached and a second configuration after being detached.
  36. 66. A catheter system as in claim 65 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
  37. 67. A catheter system as in claim 61 wherein said detachable body comprises a polymer material.
  38. 68. A catheter system as in claim 61 further comprising an introducer through which said elongate body is inserted.
  39. 69. A catheter system as in claim 61 wherein said detachable body has a surface which attaches to said scar formation.
  40. 70. A method for sterilizing a female patient, said method comprising:
    delivering a body transcervically into the female patient, said body including a non-biodegradable material;
    delivering energy to a surrounding tissue of a fallopian tube of said female patient;
    wherein a scar formation in a region of the surrounding tissue permanently attaches to the body.
  41. 71. The method of claim 70 wherein the energy comprises electrical energy and wherein the scar formation encapsulates said body.
  42. 72. A method as in claim 70 wherein said body is resilient and imposes an anchoring force against said surrounding tissue.
  43. 73. A method as in claim 70 wherein an elongated instrument assembly delivers said body and is detachably coupled to said body.
  44. 74. A method as in claim 70 wherein said body is not expelled from said fallopian tube.
  45. 75. A method as in claim 70 wherein said body comprises a polymer material.
  46. 76. A method as in claim 70 wherein said body has a first configuration prior to said delivering and a second configuration after said delivering.
  47. 77. A method as in claim 76 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
  48. 78. A method as in claim 70 wherein said body comprises an open outer wall which allows tissue ingrowth into said body.
  49. 79. An intrafallopian delivery system for transcervical introduction of a device, the delivery system comprising:
    a first portion having an elongate body;
    a second portion detachably coupled to said elongate body, said second portion including a non-biodegradable material and being sized to fit within a fallopian tube in an area exposed to energy to damage tissue in said fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube and wherein said energy causes a scar formation, in said fallopian tube, which attaches to said second portion.
  50. 80. A delivery system as in claim 79 wherein said energy comprises electrical energy.
  51. 81. A delivery system as in claim 79 wherein said second portion is resilient and imposes an anchoring force against said fallopian tube.
  52. 82. A delivery system as in claim 79 wherein said energy is delivered before said second portion is detached from said elongate body.
  53. 83. A delivery system as in claim 79 wherein said second portion has a first configuration prior to being detached and a second configuration after being detached.
  54. 84. A delivery system as in claim 83 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
  55. 85. A delivery system as in claim 79 wherein said second portion comprises a polymer material.
  56. 86. A method for sterilizing a female patient, said method comprising:
    delivering a body transcervically into the female patient, said body having an open outer wall which allows tissue ingrowth into said body;
    delivering energy to a surrounding tissue of a fallopian tube of said female patient;
    wherein a scar formation in a region of the surrounding tissue permanently attaches to said body.
  57. 87. The method of claim 86 wherein the energy comprises electrical energy and wherein the scar formation encapsulates said body.
  58. 88. A method as in claim 86 wherein said body is resilient and imposes an anchoring force against said surrounding tissue.
  59. 89. A method as in claim 86 wherein an elongated instrument assembly delivers said body and is detachably coupled to said body.
  60. 90. A method as in claim 86 wherein said body is not expelled from said fallopian tube.
  61. 91. A method as in claim 86 wherein said body comprises a polymer material.
  62. 92. A method as in claim 86 wherein said body has a first configuration prior to said delivering and a second configuration after said delivering.
  63. 93. A method as in claim 92 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
  64. 94. An intrafallopian delivery system for transcervical introduction of a device, the delivery system comprising:
    a first portion having an elongate body;
    a second portion detachably coupled to said elongate body, said second portion having an open outer wall which allows tissue ingrowth into said second portion and being sized to fit within a fallopian tube in an area exposed to energy to damage tissue in said fallopian tube and being detachable from said elongate body to remain permanently within said fallopian tube and wherein said energy causes a scar formation, in said fallopian tube, which attaches to said second portion.
  65. 95. A delivery system as in claim 94 wherein said energy comprises electrical energy.
  66. 96. A delivery system as in claim 94 wherein said second portion is resilient and imposes an anchoring force against said fallopian tube.
  67. 97. A delivery system as in claim 94 wherein said energy is delivered before said second portion is detached from said elongate body.
  68. 98. A delivery system as in claim 94 wherein said second portion has a first configuration prior to being detached and a second configuration after being detached.
  69. 99. A delivery system as in claim 98 wherein said first configuration has an outer diameter which is less than an inner diameter of said fallopian tube.
  70. 100. A delivery system as in claim 94 wherein said second portion comprises a polymer material.
  71. 101. A delivery system as in claim 94 further comprising an introducer through which said elongate body is inserted.
  72. 102. A delivery system as in claim 94 wherein said second portion has a surface which attaches to said scar formation.
US10846047 1995-06-07 2004-05-14 Contraceptive transcervical fallopian tube occlusion devices and their delivery Abandoned US20040211429A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US08474779 US6176240B1 (en) 1995-06-07 1995-06-07 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US09591874 US6871650B1 (en) 1995-06-07 2000-06-12 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US10846047 US20040211429A1 (en) 1995-06-07 2004-05-14 Contraceptive transcervical fallopian tube occlusion devices and their delivery

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10846047 US20040211429A1 (en) 1995-06-07 2004-05-14 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US11497468 US8066007B2 (en) 1995-06-07 2006-07-31 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US11711444 US20070144528A1 (en) 1995-06-07 2007-02-26 Contraceptive transcervical fallopian tube occlusion devices and their delivery

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09591874 Continuation US6871650B1 (en) 1995-06-07 2000-06-12 Contraceptive transcervical fallopian tube occlusion devices and their delivery

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11497468 Continuation US8066007B2 (en) 1995-06-07 2006-07-31 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US11711444 Division US20070144528A1 (en) 1995-06-07 2007-02-26 Contraceptive transcervical fallopian tube occlusion devices and their delivery

Publications (1)

Publication Number Publication Date
US20040211429A1 true true US20040211429A1 (en) 2004-10-28

Family

ID=23884894

Family Applications (10)

Application Number Title Priority Date Filing Date
US08474779 Expired - Lifetime US6176240B1 (en) 1995-06-07 1995-06-07 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US09322636 Expired - Lifetime US6145505A (en) 1995-06-07 1999-05-28 Electrically affixed transcervical fallopian tube occlusion devices
US09591874 Expired - Fee Related US6871650B1 (en) 1995-06-07 2000-06-12 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US10113109 Expired - Lifetime US6679266B2 (en) 1995-06-07 2002-03-28 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US10779541 Abandoned US20040159324A1 (en) 1995-06-07 2004-02-12 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US10785855 Abandoned US20040163651A1 (en) 1995-06-07 2004-02-23 Transcervical fallopian tube occlusion devices and their delivery
US10846047 Abandoned US20040211429A1 (en) 1995-06-07 2004-05-14 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US10845645 Expired - Fee Related US7428904B2 (en) 1995-06-07 2004-05-14 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US11497468 Expired - Lifetime US8066007B2 (en) 1995-06-07 2006-07-31 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US11711444 Abandoned US20070144528A1 (en) 1995-06-07 2007-02-26 Contraceptive transcervical fallopian tube occlusion devices and their delivery

Family Applications Before (6)

Application Number Title Priority Date Filing Date
US08474779 Expired - Lifetime US6176240B1 (en) 1995-06-07 1995-06-07 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US09322636 Expired - Lifetime US6145505A (en) 1995-06-07 1999-05-28 Electrically affixed transcervical fallopian tube occlusion devices
US09591874 Expired - Fee Related US6871650B1 (en) 1995-06-07 2000-06-12 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US10113109 Expired - Lifetime US6679266B2 (en) 1995-06-07 2002-03-28 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US10779541 Abandoned US20040159324A1 (en) 1995-06-07 2004-02-12 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US10785855 Abandoned US20040163651A1 (en) 1995-06-07 2004-02-23 Transcervical fallopian tube occlusion devices and their delivery

Family Applications After (3)

Application Number Title Priority Date Filing Date
US10845645 Expired - Fee Related US7428904B2 (en) 1995-06-07 2004-05-14 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US11497468 Expired - Lifetime US8066007B2 (en) 1995-06-07 2006-07-31 Contraceptive transcervical fallopian tube occlusion devices and their delivery
US11711444 Abandoned US20070144528A1 (en) 1995-06-07 2007-02-26 Contraceptive transcervical fallopian tube occlusion devices and their delivery

Country Status (8)

Country Link
US (10) US6176240B1 (en)
EP (1) EP0957844B1 (en)
JP (2) JPH11506631A (en)
CA (1) CA2221332C (en)
DE (2) DE69631069D1 (en)
DK (1) DK0957844T3 (en)
ES (1) ES2210370T3 (en)
WO (1) WO1996040023A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010041900A1 (en) * 1999-12-21 2001-11-15 Ovion, Inc. Occluding device and method of use
US20030029457A1 (en) * 1996-12-18 2003-02-13 Callister Jeffrey P. Contraceptive system and method of use
US20050288551A1 (en) * 2004-04-28 2005-12-29 Ams Research Corporation Endoscopic delivery of medical devices
US20060009798A1 (en) * 2004-02-02 2006-01-12 Ams Research Corporation Methods and devices for occluding body lumens and/or enhancing tissue ingrowth
US20070244439A1 (en) * 2006-04-03 2007-10-18 Ams Research Corporation Linear Motion Delivery System for Female Sterilization Device
US20100036412A1 (en) * 2008-08-06 2010-02-11 Boston Scientific Scimed,Inc. Vaso-occlusive devices with textured surfaces
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8235047B2 (en) 2006-03-30 2012-08-07 Conceptus, Inc. Methods and devices for deployment into a lumen
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US9713549B2 (en) 2004-02-02 2017-07-25 Bayer Healthcare Llc Contraceptive with permeable and impermeable components
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US10111687B2 (en) 2017-10-25 2018-10-30 Femasys, Inc. Methods and devices for conduit occlusion

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6705323B1 (en) * 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6176240B1 (en) * 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US5885258A (en) * 1996-02-23 1999-03-23 Memory Medical Systems, Inc. Medical instrument with slotted memory metal tube
CA2311375C (en) * 1997-06-05 2008-08-12 Adiana, Inc. Method and apparatus for tubal occlusion
US6200312B1 (en) 1997-09-11 2001-03-13 Vnus Medical Technologies, Inc. Expandable vein ligator catheter having multiple electrode leads
US6309384B1 (en) 1999-02-01 2001-10-30 Adiana, Inc. Method and apparatus for tubal occlusion
US20090036840A1 (en) * 2006-11-22 2009-02-05 Cytyc Corporation Atraumatic ball tip and side wall opening
US8702727B1 (en) 1999-02-01 2014-04-22 Hologic, Inc. Delivery catheter with implant ejection mechanism
US6464628B1 (en) 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
EP1212018B1 (en) 1999-08-23 2010-12-22 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
CA2689688C (en) * 1999-08-23 2012-05-22 Christian Lowe Deployment actuation system for intrafallopian contraception
US6709667B1 (en) 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US6471635B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
EP1253880B1 (en) 2000-02-10 2005-09-14 Potencia Medical AG Controlled urinary incontinence treatment
DE60110747T2 (en) 2000-02-10 2006-02-23 Potencia Medical Ag Mechanical device for impotence treatment
US6482145B1 (en) 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
US7011624B2 (en) 2000-02-14 2006-03-14 Obtech Medical Ag Male impotence prosthesis apparatus with wireless energy supply
EP1255513B1 (en) 2000-02-14 2005-05-25 Potencia Medical AG Penile prosthesis
US20050033163A1 (en) * 2001-04-24 2005-02-10 Impres Medical, Inc. Intrauterine implant and methods of use
US20050171569A1 (en) * 2000-04-25 2005-08-04 Impres Medical, Inc. Method and apparatus for creating intrauterine adhesions
US6708056B2 (en) * 2000-04-25 2004-03-16 Impres Medical, Inc. Method and apparatus for creating intrauterine adhesions
US20050031662A1 (en) * 2001-04-24 2005-02-10 Impres Medical, Inc. Bioreactive methods and devices for treating uterine bleeding
US7033374B2 (en) * 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7029486B2 (en) * 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6605101B1 (en) 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US8715312B2 (en) * 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US9861517B2 (en) 2001-07-26 2018-01-09 Cook Medical Technologies Llc Vessel closure member, delivery apparatus, and method of inserting the member
US6780182B2 (en) 2002-05-23 2004-08-24 Adiana, Inc. Catheter placement detection system and operator interface
US7087064B1 (en) * 2002-10-15 2006-08-08 Advanced Cardiovascular Systems, Inc. Apparatuses and methods for heart valve repair
US7404824B1 (en) * 2002-11-15 2008-07-29 Advanced Cardiovascular Systems, Inc. Valve aptation assist device
US7485143B2 (en) * 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
US8187324B2 (en) * 2002-11-15 2012-05-29 Advanced Cardiovascular Systems, Inc. Telescoping apparatus for delivering and adjusting a medical device in a vessel
US7632291B2 (en) * 2003-06-13 2009-12-15 Trivascular2, Inc. Inflatable implant
US20050061329A1 (en) * 2003-09-18 2005-03-24 Conceptus, Inc. Catheter for intrafallopian contraceptive delivery
US7998112B2 (en) 2003-09-30 2011-08-16 Abbott Cardiovascular Systems Inc. Deflectable catheter assembly and method of making same
KR101140039B1 (en) * 2004-01-26 2012-05-02 (주)아모레퍼시픽 A composition that contains ginsenoside F1 and/or Compound K for skin external application
US6964274B1 (en) * 2004-06-07 2005-11-15 Ethicon, Inc. Tubal sterilization device having expanding electrodes and method for performing sterilization using the same
US7250050B2 (en) 2004-06-07 2007-07-31 Ethicon, Inc. Tubal sterilization device having sesquipolar electrodes and method for performing sterilization using the same
WO2006052940A3 (en) * 2004-11-05 2006-09-28 Asthmatx Inc Medical device with procedure improvement features
US7981152B1 (en) 2004-12-10 2011-07-19 Advanced Cardiovascular Systems, Inc. Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sites
US7815661B2 (en) 2005-01-25 2010-10-19 Tyco Healthcare Group, Lp Method and apparatus for implanting an occlusive structure
US9149602B2 (en) 2005-04-22 2015-10-06 Advanced Cardiovascular Systems, Inc. Dual needle delivery system
US20070023534A1 (en) * 2005-07-22 2007-02-01 Mingsheng Liu Water-source heat pump control system and method
US20070088321A1 (en) * 2005-09-30 2007-04-19 Clast Trading Ltd Use of bioabsorbable, biocompatible adhesives as a method of female contraception
US9017361B2 (en) 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US7647930B2 (en) * 2006-08-02 2010-01-19 ProMed, Inc. Fallopian tube occlusion devices and methods
US20100063360A1 (en) * 2006-11-28 2010-03-11 Adiana, Inc. Side-arm Port Introducer
US8443808B2 (en) 2007-03-19 2013-05-21 Hologic, Inc. Methods and apparatus for occlusion of body lumens
JP5734650B2 (en) * 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド The self-expanding prosthesis
US8992409B2 (en) 2007-10-11 2015-03-31 Peter Forsell Method for controlling flow in a bodily organ
US20090254106A1 (en) * 2007-10-11 2009-10-08 Milux Holding Sa Method for controlling flow of sperms in a uterine tube
US8795153B2 (en) 2007-10-11 2014-08-05 Peter Forsell Method for treating female sexual dysfunction
US8696543B2 (en) 2007-10-11 2014-04-15 Kirk Promotion Ltd. Method for controlling flow of intestinal contents in a patient's intestines
US20090125023A1 (en) * 2007-11-13 2009-05-14 Cytyc Corporation Electrosurgical Instrument
US10045869B2 (en) 2008-01-29 2018-08-14 Peter Forsell Apparatus for treating obesity and reflux disease
US20100006105A1 (en) * 2008-07-08 2010-01-14 Carter Phillip J Apparatus and methods for occluding a fallopian tube
EP3120896A1 (en) 2008-10-10 2017-01-25 Kirk Promotion LTD. A system, an apparatus, and a method for treating a sexual dysfunctional female patient
CA2776450C (en) 2008-10-10 2018-08-21 Peter Forsell Heart help device, system, and method
WO2010042013A1 (en) 2008-10-10 2010-04-15 Milux Holding Sa Heart help device, system, and method
EP2349170A4 (en) 2008-10-10 2012-05-09 Milux Holding Sa Apparatus, system and operation method for the treatment of female sexual dysfunction
US20100114151A1 (en) * 2008-10-27 2010-05-06 Mujwid James R Methods and devices for deployment into a lumen
US8347887B2 (en) 2008-12-23 2013-01-08 Ams Research Corporation Devices and methods for reversal of permanent sterilization
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US8231619B2 (en) * 2010-01-22 2012-07-31 Cytyc Corporation Sterilization device and method
WO2011110177A1 (en) 2010-03-09 2011-09-15 Lina Medical Aps Contraceptive device
US8550086B2 (en) 2010-05-04 2013-10-08 Hologic, Inc. Radiopaque implant
JP5990524B2 (en) 2010-10-18 2016-09-14 バイオセプティブ,インコーポレイテッド Apparatus and method for inserting a tool or agent into the body cavity
WO2012155093A1 (en) 2011-05-11 2012-11-15 Microvention, Inc. Device for occluding a lumen
US9017366B2 (en) * 2011-08-19 2015-04-28 Empirilon Technology, Llc Methods and systems for performing intralumenal procedures
CN102949261B (en) * 2012-10-25 2014-09-10 中国人民解放军第三军医大学第一附属医院 Special-shaped anti-dropping seminiferous duct sterilization apparatus
US9180040B2 (en) 2013-10-18 2015-11-10 Contramed, Llc Intrauterine device with retrieval thread
WO2015131081A1 (en) * 2014-02-27 2015-09-03 Incumedx, Inc. Embolic framing microcoils

Citations (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422813A (en) * 1965-06-21 1969-01-21 Dow Corning Method for sterilization of males
US3561438A (en) * 1967-04-04 1971-02-09 Robert Canel Gynaecological device
US3563235A (en) * 1968-09-18 1971-02-16 Searle & Co Intrauterine contraceptive method
US3722500A (en) * 1970-12-29 1973-03-27 R Robinson Abortive device and method
US3803308A (en) * 1968-09-18 1974-04-09 Searle & Co Method of contraception with a soluble non-toxic copper or zinc compound
US3805767A (en) * 1973-02-26 1974-04-23 Erb Rene Method and apparatus for non-surgical, reversible sterilization of females
US3858571A (en) * 1973-07-02 1975-01-07 Arthur I Rudolph Cornual plug
US3858586A (en) * 1971-03-11 1975-01-07 Martin Lessen Surgical method and electrode therefor
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US3938527A (en) * 1973-07-04 1976-02-17 Centre De Recherche Industrielle De Quebec Instrument for laparoscopic tubal cauterization
US4003380A (en) * 1974-09-05 1977-01-18 F.L. Fisher Bipolar coagulation instrument
US4085743A (en) * 1976-03-02 1978-04-25 In Bae Yoon Multiple occlusion ring applicator and method
US4135495A (en) * 1975-05-21 1979-01-23 Borgen Jennings O Method and means for reversible sterilization
US4136695A (en) * 1975-07-09 1979-01-30 Gynetech-Denver, Inc. Transvaginal sterilization instrument
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4143656A (en) * 1977-03-28 1979-03-13 Ortho Pharmaceutical Corporation Instrument and method for inserting an intrauterine contraceptive device
US4158050A (en) * 1978-06-15 1979-06-12 International Fertility Research Programme Method for effecting female sterilization without surgery
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis
US4185618A (en) * 1976-01-05 1980-01-29 Population Research, Inc. Promotion of fibrous tissue growth in fallopian tubes for female sterilization
US4207891A (en) * 1978-10-10 1980-06-17 Population Research Incorporated Dispensing instrument with supported balloon
US4245623A (en) * 1978-06-06 1981-01-20 Erb Robert A Method and apparatus for the hysteroscopic non-surgical sterilization of females
US4246896A (en) * 1978-10-30 1981-01-27 Dynatech Corp. Intracervical cuff (ICC) for contraception and prevention of venereal disease and applicator therefor
US4326511A (en) * 1979-10-05 1982-04-27 Zimerman Clota E Intrauterine contraceptive device
US4374523A (en) * 1974-10-29 1983-02-22 Yoon In B Occlusion ring applicator
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4509504A (en) * 1978-01-18 1985-04-09 Medline Ab Occlusion of body channels
US4523590A (en) * 1982-10-25 1985-06-18 Wilfred Roth Method and device for reversible sterilization in mammals
US4572162A (en) * 1984-01-23 1986-02-25 Ortho Pharmaceutical (Canada) Ltd. Method for the detection, location and extraction of an intrauterine device
US4574806A (en) * 1984-10-01 1986-03-11 Cordis Corporation Tunnelling device for peripheral vascular reconstruction
US4579110A (en) * 1982-03-15 1986-04-01 Jacques Hamou Tubular pessary as a contraceptive means
US4638803A (en) * 1982-09-30 1987-01-27 Rand Robert W Medical apparatus for inducing scar tissue formation in a body
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4717387A (en) * 1983-03-31 1988-01-05 Sumitomo Electric Industries Ltd. Catheter
US4724832A (en) * 1984-09-18 1988-02-16 Strubel Bernd Jochen Size-variable intrauterine pressay and contraceptive device
US4727866A (en) * 1984-01-23 1988-03-01 Ortho Pharmaceutical (Canada) Ltd. Intrauterine device detection and removal system
US4731052A (en) * 1987-01-14 1988-03-15 Seitz Jr H Michael Method for removing tissue and living organisms
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4805618A (en) * 1985-08-08 1989-02-21 Olympus Optical Co., Ltd. Oviduct closing apparatus
US4808399A (en) * 1985-12-11 1989-02-28 Ceskoslovenska Akademie Ved Composition for diagnosing the transport function of the fallopian tube and a method for preparing said composition
US4821741A (en) * 1987-04-10 1989-04-18 Mohajer Reza S Barrier contraceptive
US4824434A (en) * 1987-01-14 1989-04-25 Seitz Jr H Michael Apparatus used in a method for removing tissue and living organisms from human body cavities
US4932422A (en) * 1989-06-12 1990-06-12 Ragheb Gamal A Contraceptive device
US4932421A (en) * 1989-01-23 1990-06-12 Steven Kaali Electrified intrauterine device
US4983177A (en) * 1990-01-03 1991-01-08 Wolf Gerald L Method and apparatus for reversibly occluding a biological tube
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5002552A (en) * 1987-11-10 1991-03-26 Donn Casey Surgical clip
US5095917A (en) * 1990-01-19 1992-03-17 Vancaillie Thierry G Transuterine sterilization apparatus and method
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
US5176692A (en) * 1991-12-09 1993-01-05 Wilk Peter J Method and surgical instrument for repairing hernia
US5192301A (en) * 1989-01-17 1993-03-09 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
US5195964A (en) * 1991-12-05 1993-03-23 Research And Education Institute, Inc. Transcervical catheterization cannula
US5197978A (en) * 1991-04-26 1993-03-30 Advanced Coronary Technology, Inc. Removable heat-recoverable tissue supporting device
US5207684A (en) * 1992-04-13 1993-05-04 Neuro Navigational Corporation Sheath for shunt placement for hydrocephalus
US5304195A (en) * 1991-12-12 1994-04-19 Target Therapeutics, Inc. Detachable pusher-vasoocclusive coil assembly with interlocking coupling
US5304194A (en) * 1991-10-02 1994-04-19 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5303719A (en) * 1992-08-14 1994-04-19 Wilk Peter J Surgical method and associated instrument assembly
US5304228A (en) * 1990-02-23 1994-04-19 Prince Martin R Method for making optical fiber with atraumatic rounded end for use in laser angioplasty
US5312415A (en) * 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US5377668A (en) * 1993-04-12 1995-01-03 Optimed Technologies, Inc. Apparatus and method for endoscopic diagnostics and therapy
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5382260A (en) * 1992-10-30 1995-01-17 Interventional Therapeutics Corp. Embolization device and apparatus including an introducer cartridge and method for delivering the same
US5389089A (en) * 1992-10-13 1995-02-14 Imagyn Medical, Inc. Catheter with angled ball tip for fallopian tube access and method
US5389100A (en) * 1991-11-06 1995-02-14 Imagyn Medical, Inc. Controller for manipulation of instruments within a catheter
US5411549A (en) * 1993-07-13 1995-05-02 Scimed Life Systems, Inc. Selectively expandable, retractable and removable stent
US5499995A (en) * 1994-05-25 1996-03-19 Teirstein; Paul S. Body passageway closure apparatus and method of use
US5507768A (en) * 1991-01-28 1996-04-16 Advanced Cardiovascular Systems, Inc. Stent delivery system
US5514176A (en) * 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
US5601593A (en) * 1995-03-06 1997-02-11 Willy Rusch Ag Stent for placement in a body tube
US5601600A (en) * 1995-09-08 1997-02-11 Conceptus, Inc. Endoluminal coil delivery system having a mechanical release mechanism
US5624461A (en) * 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US5624449A (en) * 1993-11-03 1997-04-29 Target Therapeutics Electrolytically severable joint for endovascular embolic devices
US5718711A (en) * 1992-11-18 1998-02-17 Target Therapeutics, Inc. Ultrasoft embolism devices and process for using them
US5725777A (en) * 1991-12-16 1998-03-10 Prismedical Corporation Reagent/drug cartridge
US5746692A (en) * 1994-05-05 1998-05-05 Imagen Medical, Inc. Catheter and endoscope system with distal protruding ball tip and method
US5749915A (en) * 1988-08-24 1998-05-12 Focal, Inc. Polymeric endoluminal paving process
US5755773A (en) * 1996-06-04 1998-05-26 Medtronic, Inc. Endoluminal prosthetic bifurcation shunt
US5858571A (en) * 1996-08-30 1999-01-12 Shin-Etsu Chemical Co., Ltd. Method of producing hydrogen absorbing alloy powder, and electrode using hydrogen absorbing alloy powder produced by said method
US5876398A (en) * 1994-09-08 1999-03-02 Medtronic, Inc. Method and apparatus for R-F ablation
US5885601A (en) * 1996-04-05 1999-03-23 Family Health International Use of macrolide antibiotics for nonsurgical female sterilization and endometrial ablation
US5895749A (en) * 1994-10-31 1999-04-20 Beth Israel Deaconess Medical Center Male fertility and contraception home test kits
US5897551A (en) * 1990-03-23 1999-04-27 Myriadlase, Inc. Medical device for applying high energy light and heat for gynecological sterilization procedures
US6019757A (en) * 1995-07-07 2000-02-01 Target Therapeutics, Inc. Endoluminal electro-occlusion detection apparatus and method
US6042590A (en) * 1997-06-16 2000-03-28 Novomedics, Llc Apparatus and methods for fallopian tube occlusion
US6066139A (en) * 1996-05-14 2000-05-23 Sherwood Services Ag Apparatus and method for sterilization and embolization
US6068626A (en) * 1997-06-05 2000-05-30 Adiana, Inc. Method and apparatus for tubal occlusion
US6178354B1 (en) * 1998-12-02 2001-01-23 C. R. Bard, Inc. Internal mechanism for displacing a slidable electrode
US6176240B1 (en) * 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6187027B1 (en) * 1995-04-28 2001-02-13 Target Therapeutics, Inc. Vaso-occlusive devices with heat secured polymer fiber
US20020013589A1 (en) * 1996-12-18 2002-01-31 Ovion, Inc. Contraceptive system and method of use
US6357443B1 (en) * 1998-10-22 2002-03-19 Synergyn Technologies, Inc. Removable fallopian tube plug and associated methods
US6526979B1 (en) * 1995-06-07 2003-03-04 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US20050045183A1 (en) * 1996-12-18 2005-03-03 Ovion, Inc. Methods and devices for occluding body lumens and/or for delivering therapeutic agents

Family Cites Families (155)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29345A (en) * 1860-07-24 Martin shirk
US2102270A (en) 1935-11-29 1937-12-14 Mortimer N Hyams Electrosurgical device
US2365296A (en) 1943-06-15 1944-12-19 Marie E Schimpf Inflatable pessary
US3042030A (en) 1958-11-25 1962-07-03 Read Thane Spherical type insert plug for body passageway and tool therefor
US3334629A (en) 1964-11-09 1967-08-08 Bertram D Cohn Occlusive device for inferior vena cava
US3404682A (en) 1965-11-17 1968-10-08 Tassette Inc Vaginal cup and means for inserting same
US3405711A (en) 1966-07-22 1968-10-15 Maurice I. Bakunin Intrauterine contraceptive device
US3467090A (en) 1967-05-03 1969-09-16 Phillip B Zollett Self-retaining occlusive stem pessary
US3463141A (en) 1967-05-15 1969-08-26 Casimir Mozolf Male contraceptive
US4040417A (en) 1970-12-01 1977-08-09 G. D. Searle & Co. Intrauterine device
US3598115A (en) 1969-04-08 1971-08-10 Herbert W Horne Jr Intra-uterine contraceptive device
US3675639A (en) 1970-05-11 1972-07-11 Hugo S Cimber Device for and method of temporary sterilizing a female
US3680542A (en) 1970-05-11 1972-08-01 Hugo S Cimber Device for occlusion of an oviduct
US3620212A (en) 1970-06-15 1971-11-16 Robert D Fannon Jr Intrauterine contraceptive device
US3675642A (en) 1970-07-23 1972-07-11 Peter Herent Lord Rectal cone for use in postoperative treatment
US3687129A (en) 1970-10-02 1972-08-29 Abcor Inc Contraceptive device and method of employing same
FR2110697A5 (en) 1970-10-27 1972-06-02 Rhone Poulenc Sa
US3760806A (en) * 1971-01-13 1973-09-25 Alza Corp Helical osmotic dispenser with non-planar membrane
FI55343C (en) 1971-05-11 1979-07-10 Sandoz Ag Foerfarande Foer framstaellning of nya, blodtryckssaenkande 3-hydrazinopyrido (4,3-c) pyridazinderivat
US3763856A (en) 1971-11-19 1973-10-09 T Blomberg Inserter for intra-uterine contraceptive device
US3768102A (en) 1972-02-03 1973-10-30 Univ Utah Implantable artificial urethral valve
US3840016A (en) 1972-03-10 1974-10-08 H Lindemann Electrocoagulation-bougie for the intrauterine tube sterilization
DE2220117C3 (en) 1972-04-25 1975-01-09 Bleier, Waldemar, Dr.Med., 6630 Saarlouis
JPS4967325A (en) * 1972-10-31 1974-06-29
USRE29345E (en) 1973-02-26 1977-08-09 The Franklin Institute Method and apparatus for non-surgical, reversible sterilization of females
GB1465684A (en) 1973-07-27 1977-02-23 Emmett L Contraceptive device
US4111196A (en) * 1973-07-27 1978-09-05 Lionel C. R. Emmett Intrauterine contraceptive device of c or omega form with tubular inserter and method of placement
US3895634A (en) * 1973-10-18 1975-07-22 Rapid American Corp Tampon inserter
US3918431A (en) 1974-01-11 1975-11-11 Manfred Sinnreich Fallopian tube obturating device
GB1460077A (en) 1974-01-15 1976-12-31 Brundin J O Contraceptive device
DE2404605A1 (en) 1974-01-31 1975-08-07 Brundin Jan Olof Elongate intrauterine contraceptive element - has plug for each fallopian tube opening, joined by bridge element
US3982542A (en) * 1975-03-12 1976-09-28 Ford John L Electroresectroscope and method of laparoscopic tubal sterilization
NL7504321A (en) 1975-04-11 1976-10-13 Philips Nv A device for sterilization by means of transuteriene tubacoagulatie.
DE2525650C3 (en) 1975-06-09 1978-05-24 B. Braun Melsungen Ag, 3508 Melsungen
US4416660A (en) 1975-07-09 1983-11-22 Dafoe Charles A Method of transvaginal sterilization
DE2537620A1 (en) 1975-08-23 1977-02-24 Lothar Dr Med Popp Balloon pessary for blocking fallopian tubes - is inflatable double balloon containing X:ray opaque thread in wall
FI54762C (en) 1976-08-20 1979-03-12 Em Set Oy An apparatus Foer tilltaeppning of missbildningar Science Brott i hjaernans blodkaerl with a gummipaose
US4160446A (en) 1977-08-12 1979-07-10 Abcor, Inc. Apparatus for and method of sterilization by the delivery of tubal-occluding polymer
GB2010728A (en) 1977-11-18 1979-07-04 Wolf Gmbh Richard Forceps for grasping and applying a fallopian tube plug and a plug
DE2803685C2 (en) 1978-01-27 1987-01-08 Aktiebolag Medline, Stockholm, Se
NL7810696A (en) 1978-10-26 1980-04-29 Verschoof K J H Contraceptive device, and devices for placing thereof.
ES239677Y (en) 1978-11-23 1979-06-16 Sopena Quesada Angel intrauterine spermicide
GB2038186A (en) 1978-12-21 1980-07-23 S P F Pianificazione Della Fam Contraceptive devices
DE2913036C2 (en) 1979-03-31 1983-10-20 Lothar W. Dr.Med. 2000 Hamburg De Popp
US4485814A (en) 1979-09-05 1984-12-04 Yoon In B One-piece compound elastic occluding member
EP0070068B1 (en) 1981-07-14 1985-11-21 Cimber, Hugo, Dr. med. Occlusive pessary
US4537186A (en) 1982-05-17 1985-08-27 Verschoof Karel J H Contraceptive device
DE3367159D1 (en) 1983-01-20 1986-12-04 Cimber Hugo Occlusive pessary
GB8318239D0 (en) 1983-07-06 1983-08-10 El Madani H Intra-uterine contraceptive device
CA1295796C (en) 1984-03-27 1992-02-18 Conrad Whyne Biodegradable matrix and methods for producing same
US4601698A (en) 1984-09-17 1986-07-22 Moulding Jr Thomas S Method of and instrument for injecting a fluid into a uterine cavity and for dispersing the fluid into the fallopian tubes
JPS6198254A (en) 1984-10-19 1986-05-16 Raychem Corp Prosthetic stent
US4606336A (en) 1984-11-23 1986-08-19 Zeluff James W Method and apparatus for non-surgically sterilizing female reproductive organs
DE3665259D1 (en) 1985-07-11 1989-10-05 Cimber Hugo Occlusive pessary
US4700701A (en) 1985-10-23 1987-10-20 Montaldi David H Sterilization method and apparatus
NL8600929A (en) 1986-04-11 1987-11-02 Fundatech Sa A method for manufacturing a medicated disposable pessary, and medicated disposable pessary.
US4846834A (en) * 1986-05-27 1989-07-11 Clemson University Method for promoting tissue adhesion to soft tissue implants
US4788966A (en) 1987-05-14 1988-12-06 Inbae Yoon Plug for use in a reversible sterilization procedure
US4943290A (en) 1987-06-23 1990-07-24 Concept Inc. Electrolyte purging electrode tip
US4969458A (en) 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US5222978A (en) * 1987-08-26 1993-06-29 United States Surgical Corporation Packaged synthetic absorbable surgical elements
GB2211095B (en) 1987-10-19 1991-09-11 Anthony D Haeri Device for contraception or sterilisation
US5259836A (en) 1987-11-30 1993-11-09 Cook Group, Incorporated Hysterography device and method
US4912595A (en) * 1988-06-20 1990-03-27 Kabushiki Kaisha Route Six Simple high tension capacitor
US5163958A (en) 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
US5306226A (en) 1989-02-09 1994-04-26 Salama Fouad A Urinary control with inflatable seal and method of using same
CN1047447A (en) 1989-05-23 1990-12-05 杨西群 Fallopian tube blockage embolus and installing system
US5116318A (en) 1989-06-06 1992-05-26 Cordis Corporation Dilatation balloon within an elastic sleeve
US5065751A (en) 1990-01-03 1991-11-19 Wolf Gerald L Method and apparatus for reversibly occluding a biological tube
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5569245A (en) 1990-03-13 1996-10-29 The Regents Of The University Of California Detachable endovascular occlusion device activated by alternating electric current
US5147353A (en) * 1990-03-23 1992-09-15 Myriadlase, Inc. Medical method for applying high energy light and heat for gynecological sterilization procedures
US5071407A (en) 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5122137A (en) 1990-04-27 1992-06-16 Boston Scientific Corporation Temperature controlled rf coagulation
ES2063479T3 (en) * 1990-05-04 1995-01-01 Ciba Geigy Ag Indoles replaced.
US5364393A (en) 1990-07-02 1994-11-15 Heart Technology, Inc. Tissue dissipative recanalization catheter
US5354309A (en) 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
WO1992020290A1 (en) * 1991-05-17 1992-11-26 Innerdyne Medical, Inc. Method and device for thermal ablation
US5147370A (en) 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5474089A (en) 1991-06-26 1995-12-12 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method and device for reversible sterilization
US5226911A (en) * 1991-10-02 1993-07-13 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5346498A (en) 1991-11-06 1994-09-13 Imagyn Medical, Inc. Controller for manipulation of instruments within a catheter
US5261916A (en) * 1991-12-12 1993-11-16 Target Therapeutics Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling
US5234437A (en) * 1991-12-12 1993-08-10 Target Therapeutics, Inc. Detachable pusher-vasoocclusion coil assembly with threaded coupling
CN1035541C (en) 1991-12-14 1997-08-06 兰俊生 Woman sterilization stopper
US5222964A (en) * 1992-03-03 1993-06-29 Cooper William I Intraluminal stent
US5254132A (en) 1992-09-01 1993-10-19 Medlogic, Inc. Methods for treating suturable wounds by use of sutures and cyanoacrylate adhesives
US5469867A (en) 1992-09-02 1995-11-28 Landec Corporation Cast-in place thermoplastic channel occluder
US5250071A (en) * 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
US5356388A (en) 1992-09-22 1994-10-18 Target Therapeutics, Inc. Perfusion catheter system
US5350397A (en) 1992-11-13 1994-09-27 Target Therapeutics, Inc. Axially detachable embolic coil assembly
CA2144725C (en) * 1992-11-19 2000-06-06 Uriel Hiram Chee Large diameter vasoocclusion coil
US5342348A (en) * 1992-12-04 1994-08-30 Kaplan Aaron V Method and device for treating and enlarging body lumens
US5330483A (en) * 1992-12-18 1994-07-19 Advanced Surgical Inc. Specimen reduction device
US5423849A (en) 1993-01-15 1995-06-13 Target Therapeutics, Inc. Vasoocclusion device containing radiopaque fibers
US5925059A (en) * 1993-04-19 1999-07-20 Target Therapeutics, Inc. Detachable embolic coil assembly
WO1994024944A1 (en) 1993-04-23 1994-11-10 Bohdan Babinec Method, device and apparatus for reversible contraceptive sterilization
DE69412474T2 (en) 1993-04-28 1998-12-17 Focal Inc Device, product, and use on the intraluminal photothermographic shaping
US5423829A (en) 1993-11-03 1995-06-13 Target Therapeutics, Inc. Electrolytically severable joint for endovascular embolic devices
CA2181453A1 (en) 1994-01-18 1995-07-20 George F. Kick Apparatus and method for venous ligation
NL9400436A (en) 1994-03-18 1995-11-01 Benedict Marie Doorschodt Blocking device for Fallopian tube and lock assembly.
US5807236A (en) 1994-05-05 1998-09-15 Imagyn Medical Inc. Catheter with guidewire and rounded enlargement and method
ES1028231Y (en) 1994-06-07 1995-05-16 Marcus Hospital Supplies S A Intrauterine device.
US5549624A (en) * 1994-06-24 1996-08-27 Target Therapeutics, Inc. Fibered vasooclusion coils
US5522836A (en) 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US5458636A (en) 1994-07-20 1995-10-17 U.S. Biomaterials Corporation Prosthetic device for repair and replacement of fibrous connective tissue
US5545210A (en) 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5562654A (en) 1994-10-28 1996-10-08 University Of Kentucky Research Foundation Time-released delivery system
US5578074A (en) 1994-12-22 1996-11-26 Target Therapeutics, Inc. Implant delivery method and assembly
US5630797A (en) 1995-01-17 1997-05-20 Imagyn Medical, Inc. Everting catheter system and method of utilizing the same
US5537300A (en) * 1995-02-01 1996-07-16 Kraco Enterprises, Inc. Control panel
EP0734697B1 (en) * 1995-03-30 2002-10-30 Boston Scientific Limited System for the implantation of liquid coils with secondary shape
US6638291B1 (en) * 1995-04-20 2003-10-28 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US5639277A (en) * 1995-04-28 1997-06-17 Target Therapeutics, Inc. Embolic coils with offset helical and twisted helical shapes
US5534007A (en) 1995-05-18 1996-07-09 Scimed Life Systems, Inc. Stent deployment catheter with collapsible sheath
US5766160A (en) 1995-06-06 1998-06-16 Target Therapeutics, Inc. Variable stiffness coils
JPH11506632A (en) 1995-06-07 1999-06-15 コンセプタス インコーポレイテッド Fallopian tube obstruction contraceptive device having a mechanical fallopian tube mounting portion
US5582619A (en) 1995-06-30 1996-12-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US5743905A (en) * 1995-07-07 1998-04-28 Target Therapeutics, Inc. Partially insulated occlusion device
US5766203A (en) 1995-07-20 1998-06-16 Intelliwire, Inc. Sheath with expandable distal extremity and balloon catheters and stents for use therewith and method
US5690842A (en) 1995-09-12 1997-11-25 Zimmer, Inc. Orthopaedic wire with an enlarged end and method of forming the same
GB9519982D0 (en) 1995-09-30 1995-12-06 Magos Adam L Device
US6090063A (en) * 1995-12-01 2000-07-18 C. R. Bard, Inc. Device, system and method for implantation of filaments and particles in the body
US5843158A (en) 1996-01-05 1998-12-01 Medtronic, Inc. Limited expansion endoluminal prostheses and methods for their use
US6270495B1 (en) 1996-02-22 2001-08-07 Radiotherapeutics Corporation Method and device for enhancing vessel occlusion
US5582649A (en) * 1996-02-29 1996-12-10 The United States Of America As Represented By The Secretary Of The Air Force Wafer transfer apparatus for use in a film deposition furnace
US5649949A (en) * 1996-03-14 1997-07-22 Target Therapeutics, Inc. Variable cross-section conical vasoocclusive coils
US5792154A (en) * 1996-04-10 1998-08-11 Target Therapeutics, Inc. Soft-ended fibered micro vaso-occlusive devices
CA2253289A1 (en) 1996-05-16 1997-11-20 Roderick L. Mackenzie Emergency contraceptive kit
WO1997049345A1 (en) 1996-06-27 1997-12-31 Chen Hank H Transcervical electroocclusive sterilization device
US5795288A (en) 1996-08-08 1998-08-18 Cohen; Kenneth L. Apparatus with valve for treating incontinence
US5772669A (en) 1996-09-27 1998-06-30 Scimed Life Systems, Inc. Stent deployment catheter with retractable sheath
US5968052A (en) 1996-11-27 1999-10-19 Scimed Life Systems Inc. Pull back stent delivery system with pistol grip retraction handle
US20010041900A1 (en) 1999-12-21 2001-11-15 Ovion, Inc. Occluding device and method of use
US5935137A (en) * 1997-07-18 1999-08-10 Gynecare, Inc. Tubular fallopian sterilization device
US6401719B1 (en) 1997-09-11 2002-06-11 Vnus Medical Technologies, Inc. Method of ligating hollow anatomical structures
DE69941894D1 (en) 1998-02-10 2010-02-25 Artemis Medical Inc Occlusion, mooring, voltage or current control device
US6080152A (en) 1998-06-05 2000-06-27 Medical Scientific, Inc. Electrosurgical instrument
US6096052A (en) 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US6309384B1 (en) 1999-02-01 2001-10-30 Adiana, Inc. Method and apparatus for tubal occlusion
US7014645B2 (en) * 1999-10-04 2006-03-21 Microvention Inc. Method of manufacturing expansile filamentous embolization devices
US6286510B1 (en) 1999-11-05 2001-09-11 Terry L. Ray Apparatus and method for preventing fluid transfer between an oviduct and a uterine cavity
US6371118B1 (en) * 2000-06-07 2002-04-16 Terry L. Ray Birth control apparatus
CA2429551A1 (en) * 2000-11-22 2002-05-30 Shepherd Medical Company Method and device for vas occlusion
US6550480B2 (en) * 2001-01-31 2003-04-22 Numed/Tech Llc Lumen occluders made from thermodynamic materials
US6599299B2 (en) 2001-06-26 2003-07-29 Leonard S. Schultz Device and method for body lumen occlusion
US6802825B2 (en) 2001-07-03 2004-10-12 Coopersurgical, Inc. Access catheter apparatus for use in minimally invasive surgery and diagnostic procedures in the uterus and fallopian tubes
US9861517B2 (en) * 2001-07-26 2018-01-09 Cook Medical Technologies Llc Vessel closure member, delivery apparatus, and method of inserting the member
US6758831B2 (en) 2001-09-24 2004-07-06 Ethicon, Inc. Device and method for aligning with the tubal ostium
US20040172051A1 (en) 2003-02-28 2004-09-02 Sundaram Ravikumar Method and apparatus for tubal occlusion
US6780182B2 (en) * 2002-05-23 2004-08-24 Adiana, Inc. Catheter placement detection system and operator interface
US20040193178A1 (en) 2003-03-26 2004-09-30 Cardiomind, Inc. Multiple joint implant delivery systems for sequentially-controlled implant deployment
US20040202694A1 (en) 2003-04-11 2004-10-14 Vascular Control Systems, Inc. Embolic occlusion of uterine arteries
US9713549B2 (en) 2004-02-02 2017-07-25 Bayer Healthcare Llc Contraceptive with permeable and impermeable components

Patent Citations (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422813A (en) * 1965-06-21 1969-01-21 Dow Corning Method for sterilization of males
US3561438A (en) * 1967-04-04 1971-02-09 Robert Canel Gynaecological device
US3563235A (en) * 1968-09-18 1971-02-16 Searle & Co Intrauterine contraceptive method
US3803308A (en) * 1968-09-18 1974-04-09 Searle & Co Method of contraception with a soluble non-toxic copper or zinc compound
US3722500A (en) * 1970-12-29 1973-03-27 R Robinson Abortive device and method
US3858586A (en) * 1971-03-11 1975-01-07 Martin Lessen Surgical method and electrode therefor
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US3805767A (en) * 1973-02-26 1974-04-23 Erb Rene Method and apparatus for non-surgical, reversible sterilization of females
US3858571A (en) * 1973-07-02 1975-01-07 Arthur I Rudolph Cornual plug
US3938527A (en) * 1973-07-04 1976-02-17 Centre De Recherche Industrielle De Quebec Instrument for laparoscopic tubal cauterization
US4003380A (en) * 1974-09-05 1977-01-18 F.L. Fisher Bipolar coagulation instrument
US4374523A (en) * 1974-10-29 1983-02-22 Yoon In B Occlusion ring applicator
US4135495A (en) * 1975-05-21 1979-01-23 Borgen Jennings O Method and means for reversible sterilization
US4136695A (en) * 1975-07-09 1979-01-30 Gynetech-Denver, Inc. Transvaginal sterilization instrument
US4185618A (en) * 1976-01-05 1980-01-29 Population Research, Inc. Promotion of fibrous tissue growth in fallopian tubes for female sterilization
US4085743A (en) * 1976-03-02 1978-04-25 In Bae Yoon Multiple occlusion ring applicator and method
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4143656A (en) * 1977-03-28 1979-03-13 Ortho Pharmaceutical Corporation Instrument and method for inserting an intrauterine contraceptive device
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis
US4509504A (en) * 1978-01-18 1985-04-09 Medline Ab Occlusion of body channels
US4245623A (en) * 1978-06-06 1981-01-20 Erb Robert A Method and apparatus for the hysteroscopic non-surgical sterilization of females
US4158050A (en) * 1978-06-15 1979-06-12 International Fertility Research Programme Method for effecting female sterilization without surgery
US4207891A (en) * 1978-10-10 1980-06-17 Population Research Incorporated Dispensing instrument with supported balloon
US4246896A (en) * 1978-10-30 1981-01-27 Dynatech Corp. Intracervical cuff (ICC) for contraception and prevention of venereal disease and applicator therefor
US4326511A (en) * 1979-10-05 1982-04-27 Zimerman Clota E Intrauterine contraceptive device
US4595000A (en) * 1982-03-15 1986-06-17 Jacques Hamou Tubular pessary as a contraceptive means
US4579110A (en) * 1982-03-15 1986-04-01 Jacques Hamou Tubular pessary as a contraceptive means
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771B1 (en) * 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4638803A (en) * 1982-09-30 1987-01-27 Rand Robert W Medical apparatus for inducing scar tissue formation in a body
US4523590A (en) * 1982-10-25 1985-06-18 Wilfred Roth Method and device for reversible sterilization in mammals
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4717387A (en) * 1983-03-31 1988-01-05 Sumitomo Electric Industries Ltd. Catheter
US4572162A (en) * 1984-01-23 1986-02-25 Ortho Pharmaceutical (Canada) Ltd. Method for the detection, location and extraction of an intrauterine device
US4727866A (en) * 1984-01-23 1988-03-01 Ortho Pharmaceutical (Canada) Ltd. Intrauterine device detection and removal system
US4724832A (en) * 1984-09-18 1988-02-16 Strubel Bernd Jochen Size-variable intrauterine pressay and contraceptive device
US4574806A (en) * 1984-10-01 1986-03-11 Cordis Corporation Tunnelling device for peripheral vascular reconstruction
US4805618A (en) * 1985-08-08 1989-02-21 Olympus Optical Co., Ltd. Oviduct closing apparatus
US4733665B1 (en) * 1985-11-07 1994-01-11 Expandable Grafts Partnership Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4808399A (en) * 1985-12-11 1989-02-28 Ceskoslovenska Akademie Ved Composition for diagnosing the transport function of the fallopian tube and a method for preparing said composition
US4824434A (en) * 1987-01-14 1989-04-25 Seitz Jr H Michael Apparatus used in a method for removing tissue and living organisms from human body cavities
US4731052A (en) * 1987-01-14 1988-03-15 Seitz Jr H Michael Method for removing tissue and living organisms
US4821741A (en) * 1987-04-10 1989-04-18 Mohajer Reza S Barrier contraceptive
US5002552A (en) * 1987-11-10 1991-03-26 Donn Casey Surgical clip
US5749915A (en) * 1988-08-24 1998-05-12 Focal, Inc. Polymeric endoluminal paving process
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5192301A (en) * 1989-01-17 1993-03-09 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
US4932421A (en) * 1989-01-23 1990-06-12 Steven Kaali Electrified intrauterine device
US4932422A (en) * 1989-06-12 1990-06-12 Ragheb Gamal A Contraceptive device
US4983177A (en) * 1990-01-03 1991-01-08 Wolf Gerald L Method and apparatus for reversibly occluding a biological tube
US5095917A (en) * 1990-01-19 1992-03-17 Vancaillie Thierry G Transuterine sterilization apparatus and method
US5304228A (en) * 1990-02-23 1994-04-19 Prince Martin R Method for making optical fiber with atraumatic rounded end for use in laser angioplasty
US5897551A (en) * 1990-03-23 1999-04-27 Myriadlase, Inc. Medical device for applying high energy light and heat for gynecological sterilization procedures
US5507768A (en) * 1991-01-28 1996-04-16 Advanced Cardiovascular Systems, Inc. Stent delivery system
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
US5197978B1 (en) * 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5197978A (en) * 1991-04-26 1993-03-30 Advanced Coronary Technology, Inc. Removable heat-recoverable tissue supporting device
US5304194A (en) * 1991-10-02 1994-04-19 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5389100A (en) * 1991-11-06 1995-02-14 Imagyn Medical, Inc. Controller for manipulation of instruments within a catheter
US5195964A (en) * 1991-12-05 1993-03-23 Research And Education Institute, Inc. Transcervical catheterization cannula
US5176692A (en) * 1991-12-09 1993-01-05 Wilk Peter J Method and surgical instrument for repairing hernia
US5304195A (en) * 1991-12-12 1994-04-19 Target Therapeutics, Inc. Detachable pusher-vasoocclusive coil assembly with interlocking coupling
US5725777A (en) * 1991-12-16 1998-03-10 Prismedical Corporation Reagent/drug cartridge
US5207684A (en) * 1992-04-13 1993-05-04 Neuro Navigational Corporation Sheath for shunt placement for hydrocephalus
US5303719A (en) * 1992-08-14 1994-04-19 Wilk Peter J Surgical method and associated instrument assembly
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5312415A (en) * 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US5389089A (en) * 1992-10-13 1995-02-14 Imagyn Medical, Inc. Catheter with angled ball tip for fallopian tube access and method
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5382260A (en) * 1992-10-30 1995-01-17 Interventional Therapeutics Corp. Embolization device and apparatus including an introducer cartridge and method for delivering the same
US5718711A (en) * 1992-11-18 1998-02-17 Target Therapeutics, Inc. Ultrasoft embolism devices and process for using them
US5377668A (en) * 1993-04-12 1995-01-03 Optimed Technologies, Inc. Apparatus and method for endoscopic diagnostics and therapy
US5411549A (en) * 1993-07-13 1995-05-02 Scimed Life Systems, Inc. Selectively expandable, retractable and removable stent
US5624449A (en) * 1993-11-03 1997-04-29 Target Therapeutics Electrolytically severable joint for endovascular embolic devices
US5746692A (en) * 1994-05-05 1998-05-05 Imagen Medical, Inc. Catheter and endoscope system with distal protruding ball tip and method
US5499995A (en) * 1994-05-25 1996-03-19 Teirstein; Paul S. Body passageway closure apparatus and method of use
US5499995C1 (en) * 1994-05-25 2002-03-12 Paul S Teirstein Body passageway closure apparatus and method of use
US5876398A (en) * 1994-09-08 1999-03-02 Medtronic, Inc. Method and apparatus for R-F ablation
US5895749A (en) * 1994-10-31 1999-04-20 Beth Israel Deaconess Medical Center Male fertility and contraception home test kits
US5514176A (en) * 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
US5601593A (en) * 1995-03-06 1997-02-11 Willy Rusch Ag Stent for placement in a body tube
US6187027B1 (en) * 1995-04-28 2001-02-13 Target Therapeutics, Inc. Vaso-occlusive devices with heat secured polymer fiber
US5624461A (en) * 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US6176240B1 (en) * 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6705323B1 (en) * 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6526979B1 (en) * 1995-06-07 2003-03-04 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6679266B2 (en) * 1995-06-07 2004-01-20 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6019757A (en) * 1995-07-07 2000-02-01 Target Therapeutics, Inc. Endoluminal electro-occlusion detection apparatus and method
US5601600A (en) * 1995-09-08 1997-02-11 Conceptus, Inc. Endoluminal coil delivery system having a mechanical release mechanism
US5746769A (en) * 1995-09-08 1998-05-05 Conceptus, Inc. Endoluminal coil delivery system having a mechanical release mechanism
US5885601A (en) * 1996-04-05 1999-03-23 Family Health International Use of macrolide antibiotics for nonsurgical female sterilization and endometrial ablation
US6066139A (en) * 1996-05-14 2000-05-23 Sherwood Services Ag Apparatus and method for sterilization and embolization
US5755773A (en) * 1996-06-04 1998-05-26 Medtronic, Inc. Endoluminal prosthetic bifurcation shunt
US5858571A (en) * 1996-08-30 1999-01-12 Shin-Etsu Chemical Co., Ltd. Method of producing hydrogen absorbing alloy powder, and electrode using hydrogen absorbing alloy powder produced by said method
US20020013589A1 (en) * 1996-12-18 2002-01-31 Ovion, Inc. Contraceptive system and method of use
US20030029457A1 (en) * 1996-12-18 2003-02-13 Callister Jeffrey P. Contraceptive system and method of use
US20050045183A1 (en) * 1996-12-18 2005-03-03 Ovion, Inc. Methods and devices for occluding body lumens and/or for delivering therapeutic agents
US6346102B1 (en) * 1997-06-05 2002-02-12 Adiana, Inc. Method and apparatus for tubal occlusion
US6068626A (en) * 1997-06-05 2000-05-30 Adiana, Inc. Method and apparatus for tubal occlusion
US6042590A (en) * 1997-06-16 2000-03-28 Novomedics, Llc Apparatus and methods for fallopian tube occlusion
US6357443B1 (en) * 1998-10-22 2002-03-19 Synergyn Technologies, Inc. Removable fallopian tube plug and associated methods
US6178354B1 (en) * 1998-12-02 2001-01-23 C. R. Bard, Inc. Internal mechanism for displacing a slidable electrode

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8707957B2 (en) 1996-12-18 2014-04-29 Bayer Essure Inc. Contraceptive system and method of use
US20030029457A1 (en) * 1996-12-18 2003-02-13 Callister Jeffrey P. Contraceptive system and method of use
US20080135054A1 (en) * 1996-12-18 2008-06-12 Jeffrey P. Callister Contraceptive system and method of use
US7398780B2 (en) 1996-12-18 2008-07-15 Ams Research Corporation Contraceptive system and method of use
US8113205B2 (en) 1996-12-18 2012-02-14 Conceptus, Inc. Contraceptive system and method of use
US20010041900A1 (en) * 1999-12-21 2001-11-15 Ovion, Inc. Occluding device and method of use
US20060009798A1 (en) * 2004-02-02 2006-01-12 Ams Research Corporation Methods and devices for occluding body lumens and/or enhancing tissue ingrowth
US9713549B2 (en) 2004-02-02 2017-07-25 Bayer Healthcare Llc Contraceptive with permeable and impermeable components
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US9308023B2 (en) 2004-02-25 2016-04-12 Femasys Inc. Methods and devices for conduit occlusion
US9402762B2 (en) 2004-02-25 2016-08-02 Femasys Inc. Methods and devices for conduit occlusion
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US8316853B2 (en) 2004-02-25 2012-11-27 Femasys Inc. Method and devices for conduit occlusion
US8316854B2 (en) 2004-02-25 2012-11-27 Femasys Inc. Methods and devices for conduit occlusion
US8324193B2 (en) 2004-02-25 2012-12-04 Femasys Inc. Methods and devices for delivery of compositions to conduits
US9839444B2 (en) 2004-02-25 2017-12-12 Femasys Inc. Methods and devices for conduit occlusion
US9220880B2 (en) 2004-02-25 2015-12-29 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8695606B2 (en) 2004-02-25 2014-04-15 Femasys Inc. Methods and devices for conduit occlusion
US9034053B2 (en) 2004-02-25 2015-05-19 Femasys Inc. Methods and devices for conduit occlusion
US8726906B2 (en) 2004-02-25 2014-05-20 Femasys Inc. Methods and devices for conduit occlusion
US8336552B2 (en) 2004-02-25 2012-12-25 Femasys Inc. Methods and devices for conduit occlusion
US20050288551A1 (en) * 2004-04-28 2005-12-29 Ams Research Corporation Endoscopic delivery of medical devices
US20100168514A1 (en) * 2004-04-28 2010-07-01 Callister Jeffrey P Endoscopic delivery of medical devices
US8707958B2 (en) 2006-03-30 2014-04-29 Bayer Essure Inc. Methods and devices for deployment into a lumen
US8235047B2 (en) 2006-03-30 2012-08-07 Conceptus, Inc. Methods and devices for deployment into a lumen
US8562628B2 (en) 2006-04-03 2013-10-22 Conceptus, Inc. Linear motion delivery system for female sterilization device
US20070244439A1 (en) * 2006-04-03 2007-10-18 Ams Research Corporation Linear Motion Delivery System for Female Sterilization Device
US20100036412A1 (en) * 2008-08-06 2010-02-11 Boston Scientific Scimed,Inc. Vaso-occlusive devices with textured surfaces
US9622751B2 (en) * 2008-08-06 2017-04-18 Boston Scientific Scimed, Inc. Vaso-occlusive devices with textured surfaces
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US10111687B2 (en) 2017-10-25 2018-10-30 Femasys, Inc. Methods and devices for conduit occlusion

Also Published As

Publication number Publication date Type
US7428904B2 (en) 2008-09-30 grant
US20070144528A1 (en) 2007-06-28 application
EP0957844A1 (en) 1999-11-24 application
DE69631069T2 (en) 2004-10-07 grant
US6145505A (en) 2000-11-14 grant
JPH11506631A (en) 1999-06-15 application
US6679266B2 (en) 2004-01-20 grant
EP0957844B1 (en) 2003-12-10 grant
US20040206358A1 (en) 2004-10-21 application
JP2006314809A (en) 2006-11-24 application
DK0957844T3 (en) 2004-03-29 grant
US20070044808A1 (en) 2007-03-01 application
WO1996040023A1 (en) 1996-12-19 application
US6871650B1 (en) 2005-03-29 grant
DK957844T3 (en) grant
US6176240B1 (en) 2001-01-23 grant
DE69631069D1 (en) 2004-01-22 grant
US20020100480A1 (en) 2002-08-01 application
US20040159324A1 (en) 2004-08-19 application
JP4317555B2 (en) 2009-08-19 grant
EP0957844A4 (en) 2000-02-02 application
US20040163651A1 (en) 2004-08-26 application
CA2221332A1 (en) 1996-12-19 application
ES2210370T3 (en) 2004-07-01 grant
CA2221332C (en) 2009-03-17 grant
US8066007B2 (en) 2011-11-29 grant

Similar Documents

Publication Publication Date Title
US3563235A (en) Intrauterine contraceptive method
US6042590A (en) Apparatus and methods for fallopian tube occlusion
US6068626A (en) Method and apparatus for tubal occlusion
US5690671A (en) Embolic elements and methods and apparatus for their delivery
Kerin et al. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first EssureTM pbc clinical study
US20060079926A1 (en) Vasoocclusive coil with biplex windings to improve mechanical properties
US20050187561A1 (en) Methods and devices for conduit occlusion
US6168592B1 (en) Aneurysm closure device assembly
US6306153B1 (en) Vasoocclusive coil
US20060135986A1 (en) Vaso-occlusive device having pivotable coupling
EP0865773B1 (en) Catheter deliverable coiled wire thrombogenic apparatus
US20010023325A1 (en) Micro-strand cable with enhanced radiopacity
US3680542A (en) Device for occlusion of an oviduct
Valle et al. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study
US6096034A (en) Aneurysm closure device assembly
US4595000A (en) Tubular pessary as a contraceptive means
US4523590A (en) Method and device for reversible sterilization in mammals
US20030120302A1 (en) Vaso-occlusive device with serpentine shape
WO1994011051A1 (en) Large diameter vasoocclusion coil
US20070056591A1 (en) Fallopian tube occlusion devices and methods
US20050085844A1 (en) Contraceptive device and delivery system
US20030066533A1 (en) Removable fallopian tube plug and associated methods
US6357443B1 (en) Removable fallopian tube plug and associated methods
US20090178682A1 (en) Intrauterine fallopian tube occlusion device
US7506650B2 (en) Deployment actuation system for intrafallopian contraception

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAYER ESSURE INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:CONCEPTUS, INC.;REEL/FRAME:032075/0466

Effective date: 20131025